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I N T RODUC T I ON
Reactive oxygen species (ROS) are continuously pro-
duced by respiring mitochondria, and their level greatly 
depends on the mode of electron transport in the respi-
ratory chain. Forward mode of electron transport (for-
ward electron transport [FET]) and reverse mode of 
electron transport can be elicited by substrates of com-
plex I (e.g., glutamate and malate) and complex II 
(e.g., succinate), respectively (Schönfeld and Wojtczak, 
2008). The former represents the main in vivo physio-
logical pathway of electron flow.
Mitochondria produce 85–90% of cellular ROS 
(Chance et al., 1979; Balaban et al., 2005). Sources of 
ROS other than the respiratory chain include mito-
chondrial nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase (NOX4; Bedard and Krause, 2007; 
Kuroda et al., 2010), -ketoglutarate dehydrogenase 
(Starkov et al., 2004), glycerol 3-phosphate dehydroge-
nase (Andreyev et al., 2005; Adam-Vizi and Chinopoulos, 
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2006), monoamine oxidase (Kaludercic et al., 2010), and 
several others (Andreyev et al., 2005; Murphy, 2009).
Separate, but interacting, pools of the main redox 
couples (NADH/NAD+, GSH [reduced glutathione]/
GSSG [oxidized glutathione], Trx(SH)2 [reduced Trx]/
TrxSS [oxidized Trx], and NADPH/NADP+) are pres-
ent in the cytoplasm, mitochondrial intermembrane 
space (IMS), and matrix (Aon et al., 2007; Go and 
Jones, 2008; Hu et al., 2008). Redox sensors in cytoplas-
mic and mitochondrial compartments are capable of 
dynamic and rapid detection of changes in ROS levels, 
tuning the antioxidant defenses to respond to intra- or 
extracellular redox stressors that may perturb mito-
chondrial and cytosolic redox balance (Aon et al., 2007, 
2010a; Drechsel and Patel, 2010; Sheeran et al., 2010).
The H2O2 emission flux from mitochondria reflects 
the balance between the rate of H2O2 generation, sec-
ondary to superoxide production by the respiratory 
chain and its dismutation to H2O2, and the rate of 
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The net emission of hydrogen peroxide (H2O2) from mitochondria results from the balance between reactive oxygen 
species (ROS) continuously generated in the respiratory chain and ROS scavenging. The relative contribution of 
the two major antioxidant systems in the mitochondrial matrix, glutathione (GSH) and thioredoxin (Trx), has not 
been assessed. In this paper, we examine this key question via combined experimental and theoretical approaches, 
using isolated heart mitochondria from mouse, rat, and guinea pig.
As compared with untreated control mitochondria, selective inhibition of Trx reductase with auranofin along 
with depletion of GSH with 2,4-dinitrochlorobenzene led to a species-dependent increase in H2O2 emission flux of 
17, 11, and 6 fold in state 4 and 15, 7, and 8 fold in state 3 for mouse, rat, and guinea pig mitochondria, respec-
tively. The maximal H2O2 emission as a percentage of the total O2 consumption flux was 11%/2.3% for mouse in 
states 4 and 3 followed by 2%/0.25% and 0.74%/0.29% in the rat and guinea pig, respectively.
A minimal computational model accounting for the kinetics of GSH/Trx systems was developed and was able to 
simulate increase in H2O2 emission fluxes when both scavenging systems were inhibited separately or together. 
Model simulations suggest that GSH/Trx systems act in concert. When the scavenging capacity of either one of 
them saturates during H2O2 overload, they relieve each other until complete saturation, when maximal ROS 
emission occurs.
Quantitatively, these results converge on the idea that GSH/Trx scavenging systems in mitochondria are both 
essential for keeping minimal levels of H2O2 emission, especially during state 3 respiration, when the energetic 
output is maximal. This suggests that the very low levels of H2O2 emission observed during forward electron trans-
port in the respiratory chain are a result of the well-orchestrated actions of the two antioxidant systems working 
continuously to offset ROS production.
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matrix and extramitochondrial scavenging systems. The 
Redox-optimized ROS Balance hypothesis postulates 
that oxidative stress can occur at either extreme of the 
redox potential range, that is, when the intracellular 
environment is either highly reduced or oxidized (Aon 
et al., 2010a). Previously, we have shown that in permea-
bilized cardiomyocytes and mitochondria isolated from 
guinea pig hearts, the rate of ROS accumulation de-
pends on the interplay between extramitochondrial 
GSH/GSSG ratio and GSH regeneration in the mito-
chondrial matrix (Aon et al., 2007, 2010a). At suffi-
ciently oxidized redox environments, the antioxidant 
defense systems determine the extent of ROS imbal-
ance, which may result in mitochondrial dysfunction 
and contribute to contractile impairment and whole-
heart arrhythmias (Aon et al., 2006, 2009; Slodzinski 
et al., 2008; Brown et al., 2010; Biary et al., 2011).
In the present study, we quantitatively analyzed, by 
means of experimentation and computational modeling, 
the relative contribution of the two main antioxidant 
arms (GSH and Trx1/2) in modulating mitochondrial 
H2O2 emission (Fig. 1). Auranofin (AF) and dinitrochlo-
robenzene (DNCB) were used to quantitatively charac-
terize the contribution of each system separately and 
when acting together to scavenge H2O2. We combined 
experimental and modeling results to understand in 
quantitative terms the relative weight of the two major 
antioxidant systems in preventing H2O2 emission from 
mitochondria. Our investigation was performed in iso-
lated heart mitochondria from mouse, rat, and guinea 
pig, three species that are widely used in cardiovascular 
science and have different electrophysiological and con-
tractile properties. We also aimed at assessing whether dif-
ferences related with the aims of this study exist between 
species that exhibit different maximum life span poten-
tial (4, 5, and 12 yr for mouse, rat, and guinea pig, respec-
tively; Barja, 1998). This important aspect of our choice 
was stimulated by the well-established negative correla-
tion found between mitochondrial ROS and maxi-
mum life span potential (Sanz et al., 2009). Overall, 
studying mitochondria from several distinct species 
allowed us to further ascertain the general validity of 
the results obtained.
MAT E R I A L S  AND  M E THOD S
Mitochondrial isolation
Procedures for the isolation and handling of mitochondria from 
guinea pig and rat hearts were performed as previously described 
(Aon et al., 2010a,b). Mitochondria from two pooled mouse hearts 
were isolated, with slight modifications, as described in Stanley 
et al. (2011). In brief, 0.1mg/ml proteinase (bacterial, type XXIV, 
formerly called Nagarse; Sigma-Aldrich) was added immediately 
before the homogenization procedure (Aon et al., 2010b). 3 vol of 
isolation solution (75 mM sucrose, 225 mM mannitol, and 1 mM 
EGTA, pH 7.4, containing 0.2% fatty acid–free BSA; Sigma- Aldrich) 
was quickly added after homogenization to block proteinase 
H2O2 scavenging (Andreyev et al., 2005; Kowaltowski 
et al., 2009; Murphy, 2009; Stowe and Camara, 2009; 
Aon et al., 2010a). Superoxide dismutation to H2O2 is 
accomplished primarily by Mn (mitochondrial matrix), 
Cu, and Zn (cytoplasmic and mitochondrial IMS) super-
oxide dismutases (SODs), enzymes with very high rate 
constants, on the order of 800 µM s1 (Chockalingam 
et al., 2006). Superoxide can also be oxidized to O2 
independently of SOD by oxidized cytochrome c (rate 
constant of 1–10 µM s1; Butler et al., 1982) residing 
in the IMS (Korshunov et al., 1999; Han et al., 2001; 
Pasdois et al., 2011), although it has been argued that 
cytochrome c must first be released from the inner mem-
brane before it can serve as an antioxidant (Pereverzev 
et al., 2003).
The glutathione (GSH) and Trx systems are the two 
main H2O2 scavengers that have been characterized 
in mitochondria from all organs. In the mitochondrial 
matrix, the Trx system is composed of Trx reductase 2 
(TrxR2), Trx2, and peroxiredoxin 3 (Prx3). The GSH 
system encompasses the activities of glutathione reduc-
tase (GR) and glutathione peroxidase (GPx). The cyto-
plasmic TrxR1 (Iñarrea et al., 2007) and other cytoplas mic 
antioxidants, such as the GSH system (Hu et al., 2008), 
Cu, Zn SOD (SOD1), and catalase (Iñarrea et al., 2007), 
have also been found in the mitochondrial IMS.
The mitochondrial H2O2 buffering capacity main-
tains proper reduced/oxidized ratios of GSH and Trx 
pools as the result of their constitutive enzymatic activi-
ties (Kowaltowski et al., 2009; Murphy, 2009; Stowe and 
Camara, 2009). Trx2/TrxR2 does not directly scavenge 
H2O2 but instead supplies electrons to Prx3 (Pérez 
et al., 2008; Cox et al., 2010; Holmgren and Lu, 2010). 
In doing so, Trx2 shifts from a reduced to oxidized 
form. The activity of both systems, Trx2 and GSH, 
is dependent on the electron donor NADPH, whose 
reductive potential in the mitochondrial matrix is set 
by the activity of the nicotinamide nucleotide transhy-
drogenase, NADP+-dependent isocitrate dehydroge-
nase, and malic enzyme (Sazanov and Jackson, 1994; 
Rydström, 2006).
The physiological importance of the balance between 
ROS production and scavenging is underscored by 
observations in several diseases that ROS can be either 
protective or damaging (Camara et al., 2011). Diabetes 
and insulin resistance are associated with decreased 
antioxidant capacity, reflected as diminished activities 
of SOD, GPx, and GR (Styskal et al., 2012). Under 
redox-balanced conditions, H2O2 production is offset 
by matrix peroxidases, including Prx3 and Prx5 (Rhee 
et al., 2001; Cox et al., 2010), catalase (Radi et al., 
1991; Salvi et al., 2007), and GPx1 and 4 (Imai and 
Nakagawa, 2003). The cytoplasmic and mitochondrial 
redox environments play an important role in main-
taining ROS balance within cardiac myocytes. Cellular 
and mitochondrial ROS levels are highly responsive to 
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Other bioenergetic variables and ROS detection
NAD(P)H and H2O2 were determined, as previously described (Aon 
et al., 2010a,b), and monitored simultaneously with a wavelength-
scanning fluorometer (QuantaMaster; Photon Technology In-
ternational, Inc.) using the same aforementioned medium for 
measuring respiration (excluding BSA) and a multidye program 
for simultaneous online monitoring of different fluorescent 
probes. NAD(P)H was monitored by exciting mitochondrial sus-
pensions at 340 nm and collecting the emission at 450 nm. H2O2 
was detected using the Amplex red kit (Invitrogen).
Computational model formulation
A minimal model of mitochondrial ROS scavenging account-
ing for the GSH and Trx systems was formulated, taking into 
account kinetic information available (see scheme in Fig. 4 A). 
The rate expressions used in the model were formulated as 
follows. Eqs. 1 and 2 correspond to the same expressions used 
in our mitochondrial model of ROS metabolism (Cortassa 
et al., 2004):
 VGPx  = 
E  [H O ] [GSH]
[GSH] +  [H O ]
GPX
T
2 2
1 2 2 2Φ Φ
  (1)
and
   (2)VGR  = 
k  E  [GSSG] [NADPH]
[GSSG] [NADPH] + K  [NAD
GR
1
GR
T
M
GSSG PH] + K  [GSSG] + K  K
.
M
NADPH
M
GSSG
M
NADPH
 
 activity. After a first centrifugation (500 g for 10 min) to discard 
unbroken tissue and debris, the supernatant was centrifuged at 
10,000 g for 10 min to sediment the mitochondria and washed 
twice thereafter by centrifugation at 7,700 g for 5 min each, the first 
one with isolation solution in presence of BSA and the second in 
absence of BSA. In mouse heart mitochondria, respiratory control 
ratios (state 3/state 4 respirations with 5 mM glutamate + malate or 
succinate) of five or higher were obtained using this method.
Assay of mitochondrial respiration
Respiration was assayed in freshly isolated mitochondria with a 
high-throughput–automated 96-well extracellular flux analyzer 
(XF96; Seahorse Bioscience) in a medium (buffer B) containing 
137 mM KCl, 2 mM KH2PO4, 0.5 mM EGTA, 2.5 mM MgCl2, and 
20 mM HEPES at pH 7.2 and 37°C in presence of 0.2% fatty acid–
free BSA. Respiration was evaluated with substrates of complex I 
(glutamate/malate [G/M], 5 mM each). The day before the ex-
periment, each of the 96 wells of the XF96 plate was coated with 
120 µl polyethylenimine (1:15,000 dilution in buffer B of a 50% 
solution of polyethylenimine) and incubated overnight in the 
absence of CO2. The next day, the solution of polyethylenimine 
was removed by vacuum suction. After transferring appropriate 
amounts of mitochondrial suspension into each well (5–15 µg of 
mitochondrial protein), the mitochondria were spun down at 
3,000 g for 7 min at 4°C in a centrifuge with a swinging bucket 
rotor (S5700; Beckman Coulter) with a microplate adaptor. After 
centrifugation, the plate was incubated at 37°C for 20 min before 
starting the assay in the Seahorse Bioscience equipment. Mito-
chondrial protein was determined using the bicinchoninic acid 
method protein assay kit (Thermo Fisher Scientific).
Figure 1. Major pathways of mitochondrial ROS production and ROS scavenging. The scheme depicts the GSH and Trx systems in the 
mitochondrial matrix as the major H2O2 scavengers. The NADPH/NADP+ couple is the main electron donor of the large-capacity GSH 
(GSH and GSSG) and the Trx (Trxred and Trxox) systems responsible for scavenging H2O2 via GPx and Prx enzymes, respectively. GR 
and TrxR, the two reductases responsible for regenerating the reduced species of both antioxidant defenses, GSH and Trxred, are shown. 
The two inhibitors used in this work and their sites of action are highlighted: AF, the TrxR1/2 inhibitor, and DNCB, an alkylating GSH-
depleting agent. The respiratory complexes I, II, III, IV, and V (ATP synthase) in the inner mitochondrial membrane (IMM) are also 
schematized. O2 can be produced by complexes I and III from the electron transport chain through reverse electron transport (RET) 
or FET (reverse or forward modes of electron transport), which depends on NADH- or flavin adenine dinucleotide hydrogen–linked 
substrates, such as G/M or succinate (Succ), donating electrons to complex I or II, respectively. O2 conversion to H2O2 by Mn SOD and 
the tricarboxylic acid (TCA) cycle are depicted as well. In the scheme of the computational model (see Fig. 4 A), we have split the arrow 
corresponding to Prx into two processes to account for the cycle of Prx oxidation/reduction as well. These processes are denoted by VPrx 
and Vtxpx (Eqs. 3 and 5; see Computational model formulation in Materials and methods).
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The ordinary differential equation system was numerically inte-
grated with MATCONT (Dhooge et al., 2008) both for time- 
dependent behavior and continuation analysis of the steady state 
as a function of the model parameters. Mathematically, the rate 
expressions and their parameters were formulated according to 
reported experimental data (see Table 2).
Online supplemental material
This section presents additional experimental and modeling 
data. Fig. S1 displays representative traces of H2O2 emission 
obtained at different doses of AF or DNCB inhibition of the anti-
oxidant defens es that are summarized in Fig. 2. Fig. S2 shows the 
steady-state behavior of the computational model as a function of 
the para meter representing the NADPH concentration. Online 
supplemental material is available at http://www.jgp.org/cgi/
content/full/jgp.201210772/DC1.
R E S U L T S
Kinetics of H2O2 emission flux from mitochondria upon 
inhibition of either the GSH or Trx system
We measured respiratory and H2O2 emission fluxes in 
parallel from mitochondria isolated from mouse, rat, 
and guinea pig hearts. As FET corresponds to the phy-
siological mode of electron transport in the respira-
tory chain, we measured respiration in the presence of 
NADH-linked substrates (G/M, 5 mM each) without 
(state 4) or with (state 3) 1 mM ADP.
Two inhibitors, AF and DNCB, were used to selec-
tively and equally inhibit, in the matrix and IMS, the 
Trx1/2 and GSH systems, respectively (Stanley et al., 
2011). The main rationale underlying our approach 
was that the increase in ROS emission observed in re-
spiring mitochondria in the presence of each individ-
ual inhibitor represents the amount of H2O2 being 
scavenged by that antioxidant system, assuming that 
the respiratory chain is the main supplier of ROS, Mn 
SOD is not rate controlling, and both GSH and Trx1/2 
are the main scavenging systems in the mitochondrial 
matrix and IMS. Hence, the simultaneous blockade of 
both should render the maximum percentage of the 
total O2 consumption flux being diverted to ROS gen-
eration. Knowing the total increase in H2O2 emission 
Eq. 3 was derived on the basis of the experimental studies per-
formed by Sztajer et al. (2001), from which we also obtained the 
rate constants:
 VPrx  = 
E  [H O ] [Prx(SH) ]
 [Prx(SH) ] +  [H O
PrxX
T
2 2 2
2
P1 2 P2 2 2Φ Φ ]
.   (3)
Eq. 4 represents a Michaelis–Menten rate expression with two 
substrates (NADPH and TrxSS), with kinetic parameters derived 
from Pillay et al. (2009) and Eckenroth et al. (2006):
   (4)V
TrxR
 =
 
k  E  [Trx(SS)] [NADPH]
[Trx(SS)] [NADPH] +
TrxR
1
TrxR
T
 K  [NADPH] + K  [Trx(SS)] + K  K
M
TrxSS
M
T-NADPH
M
TrxSS
M
T-NADPH
.
 
The rate expression of Prx oxidation (Eq. 5) was based on the 
model of Pillay et al. (2009), with adjustable ktxpx to simulate the 
results obtained with heart mitochondria:
 VTxPx =
k  [Trx(SH) ] [Prx(SS)]
[Trx(SH) ] + K  + K
TxPx
1
2
2 M
Trx
i
TrxPx
2
2 [Trx(SH) ]  
.   (5)
The model contains the following components: (a) TrxR and 
reduced Prx (Prx(SH)2)as part of the Trx system, present in both 
matrix and IMS, which considers the reduced/oxidized species of 
Trx and Prx as state variables (both couples linked through con-
servation relationships); and (b) the GSH system, encompassing 
the activities of GPx and GR, with GSH/GSSG as state variables, 
also obeying conservation relations. In the present model, cata-
lase was not taken into account because very low concentrations 
have been detected in heart mitochondria (Radi et al., 1991) and 
because we did not observe effects on H2O2 emission after its inhi-
bition, under the same experimental conditions used in this work 
(Stanley et al., 2011).
In keeping with the main aim of the present work, which was to 
quantify the role of the GSH/Trx scavenging systems in controlling 
ROS emission from mitochondria, the following basic questions 
prompted the use of modeling: (a) are the basic biochemical 
mechanisms involved in the GSH/Trx scavenging systems suffi-
cient to quantitatively explain the experimentally measured H2O2 
emission fluxes; (b) how do the two scavenging systems behave 
kinetically when acting together with respect to H2O2 scavenging; 
and (c) is another mechanism needed in the model formulation to 
account for the observed behavior of H2O2 emission when both 
systems are inhibited, either independently or in tandem?
In this minimal model, the rate of H2O2 generation and the 
concentration of NADPH are adjustable parameters. The input 
given by the rate of H2O2 generation represents the activity 
of SOD (VSOD). The rate equations of the individual processes 
(Eqs. 1–5) have been integrated into a system of four ordinary 
differential equations (see Table 1). The concentrations of the 
redox couples GSH/GSSG, Trx(SH)2/Trx(SS), and Prx(SH)2/
Prx(SS) (oxidized Prx) are related through conservation rela-
tions (Eqs. 6–8):
GT =  [GSH] + 2 [GSSG],
  
(6)
TrxT =  [Trx(SH) ] + [Trx(SS)],2
 
 (7)
and
PrxT =  [Prx(SH) ] + [Prx(SS)].2
 
 (8)
TA B L E  1
Model differential equations
State variable Differential equation
[H2O2] d H O
dt
H O
[ ]
]2 2 2 2 = V  - k   [  - V  - V1SOD Prx GPx×
[GSH] d GSH
dt
[ ]
 = V  - VGR GPx
[Trx(SH)2] d Trx SH
dt
[ ( ) ]2  = V  - VTrxR TxPx
[Prx(SH)2] d SH
dt
[ ( ) ]Prx
TxPx Prx
2  = V  - V
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of each inhibitor differed according to species, likely 
reflecting a different participation of GSH and Trx 
systems in H2O2 scavenging.
H2O2 emission as a percentage of the total O2 
consumption flux
We then asked whether the continuous and concerted 
action of both scavenging systems was masking a higher 
flux of ROS production from the respiratory chain. To 
test this point, we applied both AF and DNCB together 
at concentrations (50 nM and 10 µM, respectively) that 
produce maximal H2O2 emission in all species analyzed. 
The total ROS flux as a percentage of the respiratory 
flux was determined from parallel measurements of O2 
consumption and H2O2 emission in the same mitochon-
drial preparation from the three species.
The results obtained after maximal inhibition of the 
GSH and Trx1/2 systems are depicted in Table 4. The 
findings suggest that the low H2O2 emission observed un-
der FET in both respiratory states 4 and 3 is a result of the 
continuous scavenging action by GSH and Trx1/2. For 
instance, the flux of H2O2 emission from rat mitochon-
dria after complete inhibition of GSH and Trx1/2 sys-
tems under FET (in nmol H2O2 min1 mg1 protein) is 
1.16 and 0.55, whereas the respiratory flux, VO2 (nmol 
min1 mg1 protein), under the same conditions is 35 
and 202 in states 4 and 3, respectively. We calculated that 
obtained at maximal inhibition with both AF and DNCB, 
we can calculate (in percentage) the extent of scaveng-
ing performed by each system.
To choose the appropriate concentration of the in-
hibitor, we performed dose-response curves for AF 
and DNCB while monitoring H2O2 emission in mito-
chondria respiring under FET in states 4 and 3. The 
results are shown in Fig. 2 for mouse (Fig. 2 A), rat 
(Fig. 2 B), and guinea pig (Fig. 2 C) mitochondria. 
Representative traces of the dynamics of H2O2 emis-
sion during state 4 and 3 respiration as a function of 
the inhibitor concentrations are shown in Fig. S1. The 
maximal AF- elicited H2O2 fluxes obtained from mouse, 
rat, and guinea pig mitochondria under states 4/3 
(Fig. 2, A–C [left graphs]) are summarized in Table 3. 
DNCB produced larger H2O2 fluxes from mouse and 
rat mitochondria in comparison with AF but similar 
ones in guinea pig (Fig. 2, A–C [right graphs]; Table 3). 
Also summarized in Table 3 are the K0.5 inhibitory con-
stants (dose of compound producing 50% of maximal 
H2O2 emission) by AF and DNCB in states 4/3 obtained 
from data in Fig. 2. Overall, the GSH-depleting agent 
increased H2O2 emission with a K0.5 approximately 
three orders of magnitude higher than the TrxR2 in-
hibitor for the mouse (0.95 µM vs. 1.32 nM) and two 
orders of magnitude for rat and guinea pig (1–2 µM vs. 
3–15 nM). The H2O2 emission levels in the presence 
Figure 2. Effect of AF or DNCB on H2O2 emission from 
heart mitochondria under FET at states 4 and 3 of respi-
ration. (A–C) Freshly isolated mitochondria (100 µg mi-
tochondrial protein [prot.]) from mouse, rat, and guinea 
pig hearts were preincubated in the absence or the pres-
ence of the indicated concentrations of AF (left graphs) or 
DNCB (right graphs) in the presence of the NADH-linked 
substrates G/M (5 mM each). Monitoring of H2O2 was 
performed with the Amplex red assay during states 4 (with 
G/M) and 3 (+1 mM ADP) of mitochondrial respiration 
(Stanley et al., 2011). The specific fluxes of H2O2 emission 
are shown. The kinetic parameters describing the fluxes 
of H2O2 emission as a function of the inhibitor concentra-
tion, Vmax and K0.5, were determined after nonlinear regres-
sion fitting of the experimental points with a hyperbolic 
Michaelis–Menten or Hill type of equation. The results 
± SEM obtained from two experiments with duplicates in 
each are represented.
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In all cases, state 4 displayed a higher percentage of 
ROS emission than state 3, with respect to respiration. 
However, it is worth noting that in state 3, the relative 
impact of mitochondrial antioxid ant system inhibition 
is greater than previously recognized in terms of control-
ling ROS emission (Table 4). To quantify this novel ob-
servation, we calculated the extent to which the H2O2 
emis sion flux was originally underestimated under 
FET in the absence of inhibitors. For example, mouse 
the H2O2 emission represents 2 and 0.25% of the total O2 
consumption flux in rat heart mitochondria under states 
4 and 3, respectively. Data for mouse and guinea pig are 
also analyzed in Table 4, where it can be appreciated that 
mitochondria from both species represent two extreme 
situations. In mouse mitochondria, H2O2 emission repre-
sents 11 and 2.3% of the total O2 consumption in states 
4 and 3, respectively, whereas in guinea pig, H2O2 rates 
amounted to only 0.7 and 0.3%.
TA B L E  3
Kinetics of H2O2 emission from mitochondria under FET in the absence or presence of inhibitors
Condition Mouse Rat Guinea pig
State 4 State 3 State 4 State 3 State 4 State 3
H2O2 emissiona Control 107 ± 1.5 82 ± 1.5 105 ± 2.5 80 ± 5 95 ± 3 62 ± 3
+AF 707 ± 65 585 ± 49 440 ± 29 271 ± 30 791 ± 92 678 ± 91
+DNCB 2085 ± 195 767 ± 165 2541 ± 210 1309 ± 144 512 ± 47 558 ± 31
K0.5 AF (nM) 1.32 ± 0.5 0.4 ± 0.2 12.5 ± 3.7 15 ± 7 3.5 ± 1.5 4.1 ± 1.9
DNCB (µM) 0.95 ± 0.27 0.8 ± 0.5 2.1 ± 0.4 2.0 ± 0.76 1.05 ± 0.16 1.7 ± 0.12
aH2O2 emission in all cases is expressed in pmol min1 mg1 protein.
TA B L E  2
Parameter values of the computational model
Symbol Value Unit Description Equation no. Reference
EGPX
T 5.0 × 103 mM Mitochondrial concentration of GPx 1 Cortassa et al., 2004
1 5.0 × 103 mM ms Constant for GPx activity 1 Cortassa et al., 2004
2 0.75 mM ms Constant for GPx activity 1 Cortassa et al., 2004
KM
GSSG 0.06 mM Km for oxidized GSH of GR 2 Cortassa et al., 2004
KM
NADPH 0.015 mM Km for NADPH of GR 2 Cortassa et al., 2004
kGR
1 0.025–0.005 ms1 Rate constant of GR 2 Cortassa et al., 2004
EGR
T 5.0 × 103 mM Mitochondrial concentration of GR 2 Cortassa et al., 2004
GT 3.0 mM Total mitochondrial pool of GSH 6 Cortassa et al., 2004
ETPrxX
1 mM Intracellular concentration of Prx 3 Cox et al., 2010
P1 3.83 mM2 ms Constant for Prx 3 activity 3 Sztajer et al., 2001
P2 0.285 mM2 ms Constant for Prx 3 activity 3 Sztajer et al., 2001
KM
TrxSS 0.05 mM Km for Trx(SS) of TrxR 4 Pillay et al., 2009; Eckenroth et al., 2006
KM
T NADPH− 0.012 mM Km for NADPH of TrxR 4 Pillay et al., 2009; Eckenroth et al., 2006
kTrxR
1 0.022–0.009 ms1 Rate constant of TrxR 4 Pillay et al., 2009; Eckenroth et al., 2006
ETrxR
T 0.025 mM Mitochondrial concentration of TrxR 4 Pillay et al., 2009
kTxPx
1 2.5 mM1 ms1 Rate constant of Prx 5 Cox et al., 2010; Adimora et al., 2010
KM
Trx 0.1 mM Km for Trx(SH)2 of Prx 5 Adimora et al., 2010
Ki
TrxPx 0.01 mM1 Inhibition constant of Prx activity by Trx(SH)2 5 Adimora et al., 2010
TrxT 0.025 mM Total mitochondrial pool of Trx 7 Cox et al., 2010
PrxT 0.15 mM Total mitochondrial pool of Prx 8 Cox et al., 2010
k1 0.1 ms1 Rate constant of H2O2 transport from mitochondria 9 Adjusteda
aThis parameter (k1) was adjusted.
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the processes taken into account (see Computational 
model formulation in Materials and methods). In this 
model scheme, the arrow pointing to H2O2 emission, 
VH2O2 emission, is in fact the resultant of the supply of 
H2O2 by VSOD minus the consumption exerted by the 
two scavenging systems, which at the steady state can be 
written as follows:
 VH O2 2emission SOD GPx Prx = V  - V  - .V  
The behavior of the model was studied as a function of 
the activity of VSOD and for various combinations of the 
maximal rates of GSH and Trx subsystems varied 
through the catalytic rate constants of GR and TrxR.
A parametric condition representing a relative cata-
lytic ratio of GR to TrxR of two was able to mimic the 
proportion contributed by each system to the scaveng-
ing observed experimentally. Fig. 4 B shows the plot of 
the rates of GPx, TrxR, and VH2O2 emission and the 
concentrations of Trx(SH)2 and GSH when the system 
is challenged with increasing H2O2 input (VSOD). The 
GSH system reached its maximal capacity at lower 
VSOD, as indicated by the consumption of GSH and the 
obser ved plateau of GPx activity. The TrxR system 
increased its rate upon saturation of the GSH system 
along with the rate of H2O2 emission. The maximal 
VH2O2 emission was attained after the H2O2 production 
exceeded the sum of the two scavenging systems, after 
which H2O2 emission increased almost proportionally 
with VSOD.
Model simulations show the time-dependent increase 
in VH2O2 when both scavenging systems are inhibited 
simultaneously (Fig. 4 C) or independently (Fig. 5, 
A and B). When simultaneously inhibited, loss of control 
over VH2O2 occurs only after both GSH and Trx(SH)2 
are completely consumed, recapitulating the experimen-
tal observations under the same conditions (Fig. 4 C). 
In fact, the 17-fold increase obtained in the simulation 
is comparable with the values reported in Table 4 for 
mitochondria in state 4 emit 1% of VO2 as H2O2; however, 
in the presence of maximal inhibition, this increased 11 
fold to 11%. Similarly, in all three species, the original 
values of H2O2 emitted per O2 consumed were underes-
timated between 4 and 11 fold under state 4 and from 6 
to 13 fold under state 3 respiration (Table 4).
The doses of inhibitors used to obtain the data 
shown in Table 4 were further tested to determine the 
effects exerted by AF and DNCB alone or together on 
VO2. In Fig. 3, we show the results obtained with mito-
chondria from guinea pig heart. The addition of 
either inhibitor alone had no effect on state 4 or state 3 
respiration (Fig. 3, A and B). However, when added 
together, AF and DNCB significantly increased state 4 
(60%) and only slightly increased (10%) state 3 res-
piration. These effects were taken into account in the 
values shown in Table 4.
Additionally, we tested the effects of the inhibitors 
given individually, or in combination, on NADH levels 
while simultaneously monitoring H2O2 emission. Other 
than increasing H2O2 flux from mitochondria (Fig. 2), AF 
and DNCB, individually or together, had no significant 
impact on the mitochondrial NADH response (normal-
ized to the initial NADH fluorescence) upon substrate 
addition (G/M and ADP; Fig. 3 C). However, before 
substrate addition, the NADH pool was more oxidized 
(50%) in mitochondria preincubated with both inhibi-
tors, consistent with the higher NADH oxidation rate indi-
rectly indicated by the higher state 4 respiration (Fig. 3 A). 
Collectively the results depicted in Figs. 2 and 3 and 
additional data (not depicted) indicate that the behavior 
of the three species analyzed was similar.
Computational modeling of the Trx and GSH  
scavenging systems
To better understand the dynamics of the concerted 
action of the GSH/Trx systems in mitochondria, we 
formulated a minimal model accounting for the known 
kinetics of the two systems. Fig. 4 A schematically depicts 
TA B L E  4
Quantitation of respiration, H2O2 emission, and electron flow diversion to ROS in isolated heart mitochondria from three different species
VO2 H2O2 emissiona Respiratory flux as H2O2 emissionb
State 4 State 3 State 4 State 3 State 4 State 3
nmol/min/mg nmol/min/mg nmol/min/mg nmol/min/mg % %
Mouse 10 ± 2 47.5 ± 8 1.8 ± 0.03 1.2 ± 0.08 11 (1 = 11 fold)c 2.3 (0.17 = 13 fold)c
Rat 35 ± 5 202 ± 38 1.16 ± 0.03 0.55 ± 0.04 2 (0.3 = 7 fold)c 0.25 (0.04 = 6 fold)c
Guinea pig 46 ± 2.6 152 ± 8.5 0.56 ± 0.01 0.48 ± 0.06 0.74 (0.2 = 4 fold)c 0.29 (0.04 = 7 fold)c
aThe H2O2 emission fluxes reported are those measured in the presence of both inhibitors simultaneously (50 nM AF + 10 µM DNCB).
bThe numbers shown correspond to the percentage of the O2 consumption flux diverted to ROS. These values are obtained from calculations using 
VO2 and H2O2 emission that are in the same units, with the values corrected for the increase in state 4 (60%; Fig. 3 A) and 3 (10%; Fig. 3 B) respiration 
produced by the presence of AF and DNCB together. For example, in the mouse in state 4 mitochondria, the H2O2 emission (=1.8) represents 11% of 
the O2 consumption flux (=10 + 6; this latter number is a result of the 60% increase in state 4 respiration, provoked by the presence of both inhibitors 
simultaneously, i.e., 10 × 0.6 = 6; see Fig. 3 A); thus, 1.8/16 × 100 = 11.2. A similar type of calculation was applied to all other cases.
cThese values represent the percentage of the respiratory flux diverted to ROS in states 4 and 3 under FET in the absence of inhibitors (see Table 3, 
Control row).
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H2O2 emission to each one of the inhibitors (Fig. 2 A). 
A 4- and 19-fold increase in H2O2 emission could be 
simulated, close to the experimentally measured rise 
of 6 and 19 fold at state 4 with AF and DNCB, respec-
tively (Fig. 2 A and Table 3).
Model simulations also showed that H2O2 emission 
is highly dependent on NADPH levels (see Fig. S2). 
When NADPH decreases below the Km of GR and TrxR 
for NADPH (15 and 12 µM, respectively), the antioxi-
dant capacity is quickly exhausted, and higher rates 
of H2O2 emission are observed (Fig. S2 and Table 2).
D I S C U S S I ON
In this work, we have addressed the following basic 
question: how much of the total flux of ROS produced 
by the respiratory chain is scavenged and, thus, is not 
accounted for in measurements of H2O2 emission from 
mitochondria? Here, we provide the following answers/
observations: (a) the actual electron flux diverted to ROS 
production rather than O2 reduction by cytochrome oxi-
dase can be much higher than previously estimated; and 
(b) the low H2O2 emission usually reported during FET 
is a result of the combined actions of the GSH and Trx1/2 
systems, which continuously limit the amount of ROS 
escaping from mitochondria.
Our quantitative analysis indicates that if the scaveng-
ing contribution is not taken into account, the extent of 
ongoing ROS generation contributed by the respiratory 
chain is severely underestimated. This evidence is shown 
in Table 4. For the mouse mitochondria and rat and 
guinea pig mitochondria, the differences in the ROS 
rate amount to 11, 7, and 4 fold during state 4 respiration 
and 13, 6, and 7 fold in state 3 respiration, respectively 
(Table 4, last two columns).
Earlier measurements in state 4 during FET con-
ducted in mitochondria from rat liver or pigeon heart 
estimated that the H2O2 emission represented 1–2% 
of the total O2 utilization (Chance et al., 1979). Other 
authors reported lower values, namely in the range of 
0.15–0.6% (see Table 5). Negligible H2O2 emission was 
purported to exist during state 3 respiration, although 
the levels were not actually determined. Our data indi-
cate values in the range of 0.02–0.04% for mitochon-
dria in state 3 from rat and guinea pig hearts; in the 
mouse, these values increased 10 times (Table 5). Our 
results point out that, without taking into account the 
ROS scavenging action, all previous values (including 
our own data; Aon et al., 2010a) represent underestima-
tions of ROS production from the respiratory chain. 
The extent of underestimation can be as high as 11 fold 
in state 4 and 13 fold in state 3 mitochondria from mouse 
(Table 4). The standard explanation of the observed 
decrease in ROS emission during the state 4 to state 3 
transition is that it results from m depolarization 
(Schönfeld and Wojtczak, 2008), which is a result of 
mouse mitochondria. As an example, in state 4 mouse 
mitochondria, the H2O2 emission in the absence of in-
hibitors represents 1% of VO2 (i.e., 10 × 0.01 = 0.1 nmol 
H2O2/min/mg protein; when the GSH and Trx systems 
are both inhibited, the H2O2 emission is 1.8 nmol 
H2O2/min/mg protein; thus, 1.8/0.1 = 18-fold increase 
in H2O2 emission). Lower values were detected in the 
case of guinea pig mitochondria (Table 4). Importantly, 
in mouse mitochondria, simulation of separate inhibi-
tion of TrxR2 (Fig. 5 A) or GR (Fig. 5 B) closely repro-
duces the shape and magnitude of the dose response of 
Figure 3. Respiration and redox behavior of mitochondria in 
the presence of AF and/or DNCB. (A and B) Freshly isolated mi-
tochondria from guinea pig heart were handled and assayed, as 
described in Materials and methods. Mitochondrial respiration 
(VO2) was monitored under FET conditions in state 4 with G/M 
(A) and state 3 after addition of 1 mM ADP (B) in the absence 
or the presence of 50 nM AF or 10 µM DNCB or both together. 
The statistical significance of the differences between treatments 
was evaluated with ANOVA using Tukey’s multiple comparison 
test (*, p < 0.05; ***, p < 0.001). (C) The same mitochondrial 
preparation was analyzed in parallel by fluorometry for NADH 
and H2O2 emission (see Table 4), which were monitored simul-
taneously after preincubation, with the concentrations of AF and 
DNCB indicated. Arrows point to substrate (G/M and ADP) 
addition. In the whisker plots, the top and the bottom of the box 
represent the 75 and 25% percentile, respectively, whereas the 
line within the box is the median; the bars indicate the maximum 
and minimum values of the distribution. The numbers on top of 
the whisker plots correspond to the mean ± SEM (n = 12, with two 
experiments). prot., protein.
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IMS compartments. In the same study, we showed that 
2,4-DNCB, an alkylating and GSH-depleting agent (Han 
et al., 2003), increases H2O2 emission, likely through 
GSH-DNCB conjugation catalyzed by GSH S-transferase 
(Novogrodsky et al., 1979). The inhibitory action of 
AF and DNCB appeared to be largely independent of 
one another, influencing H2O2 emission only, without 
substantially affecting mitochondrial energetics (m) 
and the redox status of NADH (Stanley et al., 2011). 
Notably, the participation of the Trx system is markedly 
higher than anticipated if one considers that the GSH 
concentration exceeds Trx by >100 fold. In agreement 
with previously reported values (Garcia et al., 2010), 
our measurements in mouse mitochondria indicate 
that the GSH pool is 1–1.5 mM (Stanley et al., 2011), 
whereas Trx2 has been estimated to be 10 µM (Cox 
et al., 2010). Speculatively, this could be explained by 
a closer localization of the Trx system, relative to GSH, 
to the sources of ROS in mitochondria.
Previous studies have shown a clear link between GSH 
depletion and H2O2 and O2 generation in mitochon-
dria and cells (Han et al., 2003; Aon et al., 2007, 2010a; 
Stanley et al., 2011). Apparently, in heart mitochondria, 
a certain degree of GSH depletion (30–40%) needs to 
be attained before a high H2O2 emission is manifested 
(Han et al., 2003). H2O2 emission under FET did not 
increase before overcoming a certain level of GSH 
the activation of ATP synthesis and the concomitant 
consumption of m by the ATP synthase, leading to an 
increase in proton pumping and respiration to reestab-
lish the proton-motive force.
The present findings suggest that a large portion of 
the decrease in ROS emission in state 3 is a result of the 
action of the GSH and Trx systems, which offset a signifi-
cant amount of O2 production at complex I (e.g., flavin 
mononucleotide site) or complex III (e.g., ubisemiqui-
none). At the present stage, we cannot rule out that some 
unknown fraction of the scavenging systems is not inhib-
ited by the compounds used in this work, which would 
result in even higher H2O2 production rates.
Recently, we showed that AF, an established anti-
rheumatoid gold(I) drug that also exhibits anticancer 
activity (Rackham et al., 2007; Rigobello et al., 2009), 
increased H2O2 emission from heart mitochondria by 
selectively inhibiting the TrxR/Trx/Prx system in the 
nanomolar range (<10 nM; Stanley et al., 2011). Using 
a similar approach, a very recent study from Kudin et al. 
(2012) shows the important contribution of the Trx2 
system in H2O2 detoxification operated by mitochon-
dria in rat hippocampus. Organic gold inhibitors such 
as AF (Gromer et al., 1998; Zhong et al., 1998) effec-
tively target the selenocysteine of TrxR1 or TrxR2 be-
cause selenols bind more efficiently to heavy metals. We 
assumed that AF was inhibiting TrxR in both matrix and 
Figure 4. Time-dependent and steady-state behavior of 
the computational model of GSH/Trx systems. (A) The 
scheme of the computational model as described in Ma-
terials and methods. (B) The continuation analysis of the 
steady-state behavior as a function of the rate of H2O2 pro-
vision by SOD activity (VSOD); the latter was varied between 
5 × 105 and 5.5 × 104 mM ms1, with kTrxR
1  = 0.022 ms1 and 
kGR
1  = 0.025 ms1. (C) Time-dependent simulations show-
ing the increase in the emission of H2O2 upon inhibition 
of kTrxR
1  and kGR
1 , which were adjusted from 0.022 to 
0.009 ms1 and 0.025 to 0.005 ms1, respectively, to repre-
sent the inhibitory action of AF and DNCB, respectively.
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because ROS production represents a relatively higher 
percentage of the total O2 consumption flux by mito-
chondria in comparison with previous estimations. Also, 
the participation of GSH and Trx systems in H2O2 scav-
enging may differ between different species as herein 
reported, and this divergence may become even more 
prominent with other animals of different size. This is an 
intriguing question to ponder in future studies. Finally, 
clinical trials testing the impact of antioxidants against 
acute and chronic cardiac conditions, such as ischemia/
reperfusion injury and heart failure, have been rather 
disappointing, both in terms of functional outcome and 
prevention of mortality. One obvious explanation could 
be that some of these antioxidants do not really reach 
mitochondria, which are increasingly appreciated as a 
central source of ROS under stressful energetic and 
redox conditions. Another explanation could be that 
the maximum rates of reoxidation/recycling of the 
exogenously added antioxidants limit their effective-
ness as compared with the native, finely tuned scaven-
ger pathways. Our study provides a basic mechanistic 
platform upon which future studies aimed at prevent-
ing excessive ROS emission from mitochondria can be 
designed. In this sense, the strategies of reinforcing 
the mitochondrial matrix antioxidant defenses appear 
to be in the right direction (Skulachev et al., 2009; 
Manczak et al., 2010; Dai et al., 2011; Smith et al., 
2011). As has been previously discussed (Jones and 
Go, 2010), failure of antioxidant therapy might also be 
a consequence of disruption of redox-dependent sig-
naling pathways that are vital for cells to display nor-
mal function (Styskal et al., 2012), for example the 
well-known effect of ROS to trigger inc reased expression 
of antioxidant enzymes via the Nrf2 antioxidant response 
element (Nguyen et al., 2009).
depletion (Han et al., 2003; Aon et al., 2007; Stanley 
et al., 2011). This behavior is reproduced by our mini-
mal computational model in which the onset of the 
large increase of H2O2 emission occurs only when GSH 
and Trx(SH)2 levels decrease beyond a certain value 
(Fig. 4). Our model simulations show that the individ-
ual antioxidant systems can relieve each other when 
the catalytic capacity of either of them is overwhelmed. 
As a result, the overall function of the scavenging sys-
tems is highly dependent on NADPH that, as an electron 
donor, restores their scavenging ability (Fig. S2). The 
simulation results also suggest that GSH and Trx sys-
tems act interdependently; this interdependence can 
be not only kinetic but further could involve physical 
(molecular) interaction among components. In this 
latter case, inhibition of one system can negatively 
affect the proper function of the other. This may help to 
explain the higher fluxes of H2O2 emission registered 
when each system is inhibited independently rather 
than simultaneously (compare Tables 3 and 4). This 
interesting aspect is under current investigation in 
our laboratory.
Several theoretical and pragmatic consequences arise 
from the findings reported in this work. First and fore-
most, the two main known antioxidant systems in the 
mitochondrial matrix work continuously and concertedly 
to offset ROS produced in the respiratory chain. Second, 
the H2O2 input from the respiratory chain to the scav-
enging systems is much greater than previously mea-
sured. These findings bring to the surface two additional 
relevant points: (1) the GSH/Trx systems exert a high 
degree of control over the H2O2 emission flux, which 
modulates the intramitochondrial and -cellular redox 
environment, and (2) in this context, the respiratory 
chain and the levels of O2 acquire a special importance 
TA B L E  5
Literature survey of H2O2 emission and electron flow diversion to ROS under FET in isolated mitochondria from different organs and species
Mitochondria source Species H2O2 emission O2 consumption flux 
diverted to H2O2
Reference
State 4 State 3 (State 4–State 3)
nmol/min/mg protein nmol/min/mg protein %
Heart Rat 0.02 ND 0.4–ND Hansford et al., 1997
ndet ND St-Pierre et al., 2002
0.105 0.08 0.3–0.04 This study
Pigeon 0.3–0.6 ND 2–ND Chance et al., 1979
ndet ND St-Pierre et al., 2002
Guinea pig 0.075 0.047 0.6–0.016 Aon et al., 2010a
0.095 0.062 0.2–0.04 This study
Mouse 0.107 0.082 1–0.17 This study
Liver Rat 0.19 0.08 1-2–ND Boveris et al., 1972
0.25 ND 1.82–ND Hoffman and Brookes, 2009
Skeletal muscle Rat <0.2 ND ≤0.15–ND St-Pierre et al., 2002
In all sources, FET is under G/M or Pyr/M (4–6 mM each). The only exception is St-Pierre et al. (2002), in which the data reported in the table were 
obtained with palmitoyl carnitine. ndet, non-detected.
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Figure 5. Model simulation of mitochondrial H2O2 emission 
after independent inhibition of Trx or GSH system. (A) To 
simulate AF inhibition with the computational model, the con-
centration of TrxR2 (Etrxm) was decreased from a control con-
centration of 0.002 to 108 mM. The steady-state values of H2O2 
emission were estimated for each concentration at fixed GR 
(kcgrm = 0.0152). (B) DNCB inhibition was simulated by de-
c reasing the concentration of GR (kcgrm) from a control value 
of 0.0215 mM to 108 mM and the steady-state values of H2O2 
emission estimated at each concentration while keeping TrxR2 
constant (Etrxm = 0.0035). In both cases, the percentage of inhi-
bition was calculated by dividing the control concentration over 
the corresponding TrxR2 or GR concentration. The parameters used 
in this simulation were kcgpx = 0.013 mM, VSOD = 8 × 105 mM ms1, 
kpxx = 2.5 mM, and Prx3T = 0.5 mM.
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